Kiin Bio Weekly

Kiin Bio Weekly

Home
Podcast
About
🥼 The Primer on the State of Clinical AI: Progress Without Integration
How AI is entering hospitals, and why clinicians need to be part of the conversation
 • Natasha Kilroy
EMBL-EBI’s Enzyme Motif Miner, Arc Institute's RESPLICE, and Harvard’s MEDEA
Kiin Bio's Weekly Insights
 • Natasha Kilroy
EPFL’s GLDP, UO's CyclicMPNN, and UHN’s EchoJEPA
Kiin Bio's Weekly Insights
 • Natasha Kilroy
⬡ SureChEMBL 2.0: Rebuilding Patent Chemistry for the AI Era
Deep Dive | Edition 14
 • Natasha Kilroy
Seoul National University’s FoldMason, NIH’s RNAnneal, and Harvard’s ARK
Kiin Bio's Weekly Insights
 • Natasha Kilroy
🔬BinderFlow: Making Protein Binder Design Work in Real Labs
Deep Dive | Edition 13
 • Natasha Kilroy

January 2026

Absci’s Origin-1, JKU Linz’s MolecularIQ, and Genesis’s PEARL
Kiin Bio's Weekly Insights
 • Natasha Kilroy
🧬 Designing the Building Blocks of Life: A Primer on Structural Biology
What’s your biggest time sink in early drug discovery process?
 • Natasha Kilroy
ETH Zurich’s AMP-BMS/MM, CTU Prague’s OPIA, and Planck’s AlphaDIA
Kiin Bio's Weekly Insights
 • Natasha Kilroy
CNRS Lyon’s FoldScript, Tsinghau's DrugCLIP, and YCU's ChemTSv3
Kiin Bio's Weekly Insights
 • Natasha Kilroy
🧬 MOLECULE: Why Protein Motion Changes How We Classify Drug Action
Deep Dive | Edition 12
 • Natasha Kilroy
UHN’s ECG-FM, Lorraine’s DynamicGT, and Weill Cornell’s HTS-Oracle
Kiin Bio's Weekly Insights
 • Natasha Kilroy
© 2026 KIIN AI LTD · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture